Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
08/2010
08/05/2010WO2010086629A1 Transdermal patch with extensor means
08/05/2010WO2010086441A1 Pharmaceutical composition comprising n-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride
08/05/2010WO2010086427A1 Pharmaceutical forms for the release of active compounds
08/05/2010WO2010086425A1 Pharmaceutical forms for the release of active compounds
08/05/2010WO2010086322A1 Composition comprising chicoric acid and/or derivatives thereof
08/05/2010WO2010086315A1 Pharmaceutical compositions comprising 2-oxo-1-pyrrolidine derivatives
08/05/2010WO2010086312A1 Galenic formulations of organic compounds
08/05/2010WO2010086235A1 Oil-in-water emulsions
08/05/2010WO2010086129A1 Inclusion complex comprising cinacalcet and cyclodextrin
08/05/2010WO2010086030A1 Container for pharmaceutical use for the quantitative release of a single dose for oral administration of t3 and t4 thyroid hormones in solution
08/05/2010WO2010066749A3 Ulipristal acetate tablets
08/05/2010WO2010063667A3 Pharmaceutical composition comprising ezetimibe and simvastatin
08/05/2010WO2010063476A3 Solid dosage forms of bendamustine
08/05/2010WO2010062322A3 Modulation of the immune response
08/05/2010WO2010055119A3 Pharmaceutical composition comprising pimobendan
08/05/2010WO2010023066A3 Improvements relating to pharmaceutical compositions
08/05/2010WO2010017570A3 Pharmaceutical form comprising tetrahydrobiopterin
08/05/2010WO2010006194A3 Non-covalent modification of microparticles and process of preparing same
08/05/2010WO2010005480A3 Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor
08/05/2010WO2010004253A3 Device and method for making solid beads
08/05/2010WO2009130204A3 Improved formulations for poorly permeable active pharmaceutical ingredients
08/05/2010WO2009106641A3 Compositions and methods for augmentation and regeneration of living tissue in a subject
08/05/2010US20100199362 Wnt ligands involved in blood-brain barrier development and uses therefor
08/05/2010US20100197804 Pharmaceutical compositions comprising terbinafine
08/05/2010US20100197795 Transdermal compositions
08/05/2010US20100197751 Compositions of pegylated soluble tumor necrosis factor receptors and methods of preparing
08/05/2010US20100197742 New formulations and use thereof
08/05/2010US20100197722 Treatment for basal cell carcinoma
08/05/2010US20100197719 Medicament compositions containing anticholinergically-effective compounds and betamimetics
08/05/2010US20100197701 Method of treating diabetes
08/05/2010US20100197648 Treatment of irritable bowel syndrome and related bowel disease
08/05/2010US20100197641 Formulation for lipophilic agents
08/05/2010US20100197637 Method of Treatment Using Bisphosphonic Acid
08/05/2010US20100197620 Pesticidal formulations
08/05/2010US20100196636 Indicators for detecting the presence of metabolic byproducts from microorganisms
08/05/2010US20100196513 Colon cleansing compositions and methods
08/05/2010US20100196507 Treatment of Wounds and Compositions Employed
08/05/2010US20100196495 Delivery of flu antibodies to surfaces in contact with air
08/05/2010US20100196494 Enhanced antimicrobial activity compositions of blends of plant essential oils
08/05/2010US20100196493 Method for producing stable powder compositions
08/05/2010US20100196492 Electrostatic coating of particles for drug delivery
08/05/2010US20100196491 contain at least two purified recombinant monkeypox virus proteins or peptides encoded by the open reading frames of the monkeypox ortholog genes M1R, A35R, A29L B6R, and orthologs of these proteins or peptides having 90% identity
08/05/2010US20100196490 Compositions and methods of delivery of pharmacological agents
08/05/2010US20100196489 Bone growth particles and osteoinductive composition thereof
08/05/2010US20100196488 Pharmaceutical Formulation
08/05/2010US20100196486 Methods for producing aripiprazole suspension and freeze-dried formulation
08/05/2010US20100196485 Rare earth metal compounds, methods of making, and methods of using the same
08/05/2010US20100196484 Use of expanded amorphous mineral particles for increasing the tenacity of a fragrance, scenting composition and method for treating body odours
08/05/2010US20100196483 Method for treatmentof severe and uncontrollable asthma
08/05/2010US20100196482 Polymer-encapsulated reverse micelles
08/05/2010US20100196481 Spinal cord injury, inflammation, and immune-disease: local controlled release of therapeutic agents
08/05/2010US20100196480 Graft materials containing bioactive extracellular matrices and cells
08/05/2010US20100196479 METHODS AND COMPOSITIONS COMPRISING AT LEAST ONE ALPHA3 BETA4 nAChR ANTAGONIST OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
08/05/2010US20100196478 Protein matrix materials, devices and methods of making and using thereof
08/05/2010US20100196477 Dry Mouldable drug formulation
08/05/2010US20100196476 Process for the preparation and pharmaceutical formulations for 4-quinolinones and quinolines and use thereof
08/05/2010US20100196475 Controlled release tablet formulation containing magnesium aluminometasilicate
08/05/2010US20100196474 Gastric Retentive Extended-Release Dosage Forms Comprising Combinations of a Non-Opioid Analgesic and an Opioid Analgesic
08/05/2010US20100196473 Pharmaceutical Composition Containing 6-dimethylaminomethyl-1-(3-methoxyphenyl)-cyclohexane-1,3-diol with Delayed Active Ingredient Release
08/05/2010US20100196472 Modified release compositions of milnacipran
08/05/2010US20100196471 Novel tablet dosage form
08/05/2010US20100196470 Device and method for reducing calorie intake
08/05/2010US20100196469 Pharmaceutical Formulation containing an HMG-COA Reductase Inhibitor and method for the preparation thereof
08/05/2010US20100196468 Stable pharmaceutical composition comprising a hydrosoluble vinflunine salt
08/05/2010US20100196467 Therapeutic combination of amlodipine and benazepril/benazeprilat
08/05/2010US20100196466 Drug delivery system
08/05/2010US20100196465 Stable pharmaceutical composition of a water-soluble vinorelbine salt
08/05/2010US20100196464 Orlistat pharmaceutical formulations
08/05/2010US20100196463 Methods and compositions for reduction of side effects of therapeutic treatments
08/05/2010US20100196462 Method for Manufacturing a Pharmaceutical Form of Oseltamivir Phosphate
08/05/2010US20100196461 Resuscitation fluid
08/05/2010US20100196460 Integrated Photoactive Agents for Real-Time Monitoring of Hemostasis
08/05/2010US20100196459 Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms
08/05/2010US20100196458 Modified cytokines for use in cancer therapy
08/05/2010US20100196457 Agent, pharmaceutical composition, and method for treating the ethyl alcohol and/or narcotic dependence
08/05/2010US20100196456 Emulsion preconcentrates and micellar formulations containing wood resins
08/05/2010US20100196455 Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
08/05/2010US20100196454 Dressing formulations to prevent and reduce scarring
08/05/2010US20100196453 Biphasic lipid-vesicle composition and method for treating cervical dysplasia by intravaginal delivery
08/05/2010US20100196452 Pharmaceutical compositions and methods for treating erectile dysfunction
08/05/2010US20100196451 Vaccines Containing Non-Live Antigenic Vectors
08/05/2010US20100196450 Targeting pax2 for the induction of defbi-mediated tumor immunity and cancer therapy
08/05/2010US20100196449 System and method to improve sensory function
08/05/2010US20100196448 Wound healing dressing and methods of manufacturing the same
08/05/2010US20100196447 Silk biomaterials and methods of use thereof
08/05/2010US20100196446 Drug delivery and substance transfer facilitated by nano-enhanced device having aligned carbon nanotubes protruding from device surface
08/05/2010US20100196445 Systems and methods for delivery of biologically active agents
08/05/2010US20100196444 Devices with cells cultured on flexible supports
08/05/2010US20100196443 Use of cordyceps species or extract thereof in the egg production
08/05/2010US20100196439 Angiogenesis Mechanism and Method, and Implantable Device
08/05/2010US20100196437 Medical devices having a surface including a biologically active agent therein
08/05/2010US20100196435 Materials and methods for delivering compositions to selected tissues
08/05/2010US20100196434 Combined fibnrinolytic and antimicrobial cathether and uses thetherof
08/05/2010US20100196432 Biopolymer structures
08/05/2010US20100196429 Oil-In-Water Emulsion Composition And Method For Producing The Same
08/05/2010US20100196427 Delayed-release glucocorticoid treatment of rheumatoid arthritis by improving signs and symptoms, showing major or complete clinical response and by preventing from joint damage
08/05/2010US20100196426 Use of microvesicles in diagnosis and prognosis of medical diseases and conditions
08/05/2010US20100196425 Oros push-stick for controlled delivery of active agents
08/05/2010US20100196424 Stabilization of long chain polyunsaturated oils
08/05/2010US20100196378 Removal promoters and inhibitor for apoptosis cells in vivo
1 ... 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 ... 2991